Interplay of inflammatory biomarkers in heart disease patients with depressive symptoms: An update.

Treesa P Varghese, Sharad Chand, Nila Mary Varghese, Rohit Singh, Shiv Kumar Yadav

Current problems in cardiology 2024 Mar

filter terms:

The pathophysiological mechanisms that connect heart disease and depressive disorders have been identified as abnormal endothelial function, dysregulation of the Hypothalamic Pituitary Adrenal (HPA) axis and abnormal platelet activities. Among these mechanisms, both endothelial dysfunction and HPA axis dysregulation are influenced by low grade inflammation and play significant roles in both conditions. Consequently, it is hypothesized that inflammation is an integral part of the formation of atherosclerotic plaques, linking the occurrence of heart diseases to the activation and shedding of intercellular adhesion molecules (ICAMs), especially soluble ICAM-1. This process is accompanied by the local and systemic secretion of various inflammatory markers like interleukin-6, Tumour Necrosis Factor, and C-reactive protein. Therefore, this review primarily focuses on defining the potential role of different inflammatory biomarkers in depression and heart disease and assessing whether mediators could serve as predictive biomarkers for detecting depressive symptoms in patients with heart disease. Copyright © 2023. Published by Elsevier Inc.

Citation

Treesa P Varghese, Sharad Chand, Nila Mary Varghese, Rohit Singh, Shiv Kumar Yadav. Interplay of inflammatory biomarkers in heart disease patients with depressive symptoms: An update. Current problems in cardiology. 2024 Mar;49(3):102352